(Q33293437)

25 July 2017

title

Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer (English)

1 reference

interstitial lung disease

25 July 2017

main subject

1 reference

1 reference

Charles Hugo Marquette

7

0 references

author name string

Demosthenes Makris

1

1 reference

25 July 2017

Arnaud Scherpereel

2

1 reference

25 July 2017

Marie Christine Copin

3

1 reference

25 July 2017

Guillaume Colin

4

1 reference

25 July 2017

Luc Brun

5

1 reference

25 July 2017

Jean Jacques Lafitte

6

1 reference

25 July 2017

language of work or name

English

0 references

publication date

5 August 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

150

1 reference

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963454

Severe interstitial pneumonitis associated with docetaxel administration.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963454

Fatal pulmonary toxicity resulting from treatment with gemcitabine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963454

Interstitial pneumonitis associated with ifosfamide therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963454

Interstitial pneumonia from mitomycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963454

FDA drug approval summary: erlotinib (Tarceva) tablets

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-150

Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib (Iressa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-150

Severe acute interstitial pneumonia and gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-150

Interstitial pneumonia during gefitinib treatment of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-150

Respiratory failure following vinorelbine tartrate infusion in a patient with non-small cell lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17683587

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-7-150

1 reference

Dimensions Publication ID

25 July 2017

1043763075

0 references

Fatcat ID

release_qyn72i6lsjas7dob5dn45vl4vq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qyn72i6lsjas7dob5dn45vl4vq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

1963454

1 reference

25 July 2017

1 reference